evenfolio
First TrustHealthFTXH · Nasdaq

First Trust Nasdaq Pharmaceuticals ETF (FTXH)

Price
$40.47
11 Sept 2026
Assets
$1.1B
Total net assets
Expense ratio
0.60%
Category 1.00%
Yield
1.03%
Trailing distributions
3Y CAGR
16.6%+3.0%
Category 13.5%
5Y CAGR
10.8%+8.9%
Category 1.9%
Loading NAV history…
First Trust Nasdaq Pharmaceuticals ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation
Maximum drawdown
Sharpe ratio
Sortino ratio
Beta
Alpha
Information ratio
Upside capture
Downside capture
Tracking error
Trailing returns compared with benchmark
Period1M3M6MYTD1Y3YCAGR5YCAGR10YCAGRLaunchCAGR
ETF+1.2%+12.6%+20.8%+23.4%+44.0%+16.6%+10.8%+8.4%
Health average-1.4%12.4%20.6%14.7%31.2%13.5%1.9%9.5%10.7%
Difference+2.6%+0.2%+0.3%+8.7%+12.8%+3.0%+8.9%-2.3%

Holdings

The 10 largest positions make up 52.5% of the fund.

Top holdings

Largest holdings by weight
TickerHoldingWeight
MRKMerck & Co Inc7.57%
ABBVAbbVie Inc7.01%
LLYEli Lilly and Co6.96%
BMYBristol-Myers Squibb Co6.80%
JNJJohnson & Johnson6.79%
BIIBBiogen Inc3.58%
AMGNAmgen Inc3.52%
VTRSViatris Inc3.51%
VRTXVertex Pharmaceuticals Inc3.49%
PFEPfizer Inc3.27%

Portfolio valuation

Weighted averages of what the fund holds.

P/E
27.8
P/B
4.9
P/S
2.9
P/CF
16.7

Sector allocation

Share of the equity the fund holds.

100.0%Health care1 sectors
  1. Health care100.0%

Asset mix

  • Stocks99.9%
  • Cash0.1%

ETF details

Issuer
First Trust
Category
Equity · Health
Ticker
FTXH
Exchange
Nasdaq
Inception
20 Sept 2016 (10.0 years)
Structure
Exchange Traded Fund
Expense ratio
0.60% (category 1.00%)
Holdings turnover
35% (category 51%)
Distribution yield
1.03%
Beta, 3 years
0.48
Total net assets
$1.1B

Prices and returns as of 11 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other health ETFs

Other ETFs in the Health category.

Search

Search funds, pages and tools